High rates of surveillance imaging for treated diffuse large B-cell lymphoma: Findings from a large national database Journal Article


Authors: Abel, G. A.; Vanderplas, A.; Rodriguez, M. A.; Crosby, A. L.; Czuczman, M. S.; Niland, J. C.; Gordon, L. I.; Millenson, M.; Zelenetz, A. D.; Friedberg, J. W.; LaCasce, A. S.
Article Title: High rates of surveillance imaging for treated diffuse large B-cell lymphoma: Findings from a large national database
Abstract: We aimed to characterize surveillance imaging and circumstances of relapse for patients with diffuse large B-cell lymphoma (DLBCL) in the National Comprehensive Cancer Network Non-Hodgkin's Lymphoma Outcomes Database, a prospective cohort study collecting clinical and outcome data at seven comprehensive cancer centers. Patients presenting with newly diagnosed DLBCL in remission ≥3 months after initial therapy and who had accrued 2 years of follow-up were eligible for analysis (n 625). The median number of imaging studies was 2.5/year (institutional range 0.53.5, p < 0.0001); 48.4% received only dedicated computed tomography (CT) scans, 14.6% received only positron emission tomography (PET)-inclusive modalities, 32.8% received a combination and 4.2% received no imaging. Among all eligible patients, 50 (8.0%) experienced relapse, and approximately one-quarter of subclinical relapses were detected through routine imaging. Our results suggest that despite limited data regarding its effect on outcomes, surveillance imaging is prevalent in DLBCL, and a majority of patients receive PET scans at some point during follow-up. © 2012 Informa UK, Ltd.
Keywords: adult; middle aged; major clinical study; united states; positron emission tomography; follow up; follow-up studies; physician's practice patterns; computer assisted tomography; cohort studies; image analysis; evidence based practice; recurrence; tomography, x-ray computed; diagnostic imaging; data base; cancer center; cancer regression; watchful waiting; positron-emission tomography; health services research; cancer relapse; large cell lymphoma; lymphoma, large b-cell, diffuse; databases, factual; population surveillance; diffuse large b-cell lymphoma
Journal Title: Leukemia and Lymphoma
Volume: 53
Issue: 6
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2012-06-01
Start Page: 1113
End Page: 1116
Language: English
DOI: 10.3109/10428194.2011.639882
PROVIDER: scopus
PUBMED: 22098406
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 4 June 2012" - "CODEN: LELYE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Zelenetz
    767 Zelenetz